Notices. Notice of application
317 words·~1 min read·
/register/2021/11/23/2021-25578A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-925] Bulk Manufacturer of Controlled Substances Application: Noramco AGENCY: Drug Enforcement Administration, Justice. ACTION: Notice of application. SUMMARY: Noramco, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 24, 2022.
Such persons may also file a written request for a hearing on the application on or before January 24, 2022. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on October 19, 2021, Noramco, 500 Swedes Landing Road, Wilmington, Delaware 19801-4417, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):
Controlled substance Drug code Schedule Marihuana 7360 I Tetrahydrocannabinols 7370 I Dihydromorphine 9145 I Hydromorphinol 9301 I Amphetamine 1100 II Lisdexamfetamine 1205 II Methylphenidate 1724 II Nabilone 7379 II Codeine 9050 II Dihydrocodeine 9120 II Oxycodone 9143 II Hydromorphone 9150 II Hydrocodone 9193 II Morphine 9300 II Oripavine 9330 II Thebaine 9333 II Opium extracts 9610 II Opium fluid extract 9620 II Opium, tincture 9630 II Opium, powdered 9639 II Opium, granulated 9640 II Oxymorphone 9652 II Noroxymorphone 9668 II Tapentadol 9780 II The company plans to bulk manufacture the listed controlled substances as an Active Pharmaceutical Ingredient
(API)for supply to its customers. In reference to dug codes 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration. Brian S. Besser, Acting Assistant Administrator. [FR Doc. 2021-25578 Filed 11-22-21; 8:45 am]
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Notices
Notice of application
Cites 1Cited by 0 across 0 sources